147 related articles for article (PubMed ID: 26795951)
41. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels.
Li M; Zhang Z; Hill DL; Chen X; Wang H; Zhang R
Cancer Res; 2005 Sep; 65(18):8200-8. PubMed ID: 16166295
[TBL] [Abstract][Full Text] [Related]
42. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
43. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
44. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
Chen X; Zhang M; Liu LX
Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507
[TBL] [Abstract][Full Text] [Related]
45. NFATc2 is a potential therapeutic target in human melanoma.
Perotti V; Baldassari P; Bersani I; Molla A; Vegetti C; Tassi E; Dal Col J; Dolcetti R; Anichini A; Mortarini R
J Invest Dermatol; 2012 Nov; 132(11):2652-60. PubMed ID: 22718120
[TBL] [Abstract][Full Text] [Related]
46. NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells.
Lim JH; Park JW; Min DS; Chang JS; Lee YH; Park YB; Choi KS; Kwon TK
Apoptosis; 2007 Feb; 12(2):411-21. PubMed ID: 17191121
[TBL] [Abstract][Full Text] [Related]
47. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
[TBL] [Abstract][Full Text] [Related]
48. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
49. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
[TBL] [Abstract][Full Text] [Related]
50. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract][Full Text] [Related]
51. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
52. In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs.
Sabatino MA; Previdi S; Broggini M
Int J Cancer; 2007 Feb; 120(3):506-13. PubMed ID: 17096333
[TBL] [Abstract][Full Text] [Related]
53. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
Cancer Lett; 2010 Jan; 287(1):98-108. PubMed ID: 19577358
[TBL] [Abstract][Full Text] [Related]
54. TRAIL-receptor 2-a novel negative regulator of p53.
Willms A; Schupp H; Poelker M; Adawy A; Debus JF; Hartwig T; Krichel T; Fritsch J; Singh S; Walczak H; von Karstedt S; Schäfer H; Trauzold A
Cell Death Dis; 2021 Jul; 12(8):757. PubMed ID: 34333527
[TBL] [Abstract][Full Text] [Related]
55. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
56. Exposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cells.
Vizza D; Perri A; Lofaro D; Toteda G; Lupinacci S; Leone F; Gigliotti P; Papalia T; Bonofiglio R
PLoS One; 2013; 8(11):e80113. PubMed ID: 24244623
[TBL] [Abstract][Full Text] [Related]
57. Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer.
Wahab R; Gopalan V; Islam F; Smith RA; Qiao B; Lam AK
Eur J Cell Biol; 2017 Sep; 96(6):487-495. PubMed ID: 28764863
[TBL] [Abstract][Full Text] [Related]
58. MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells.
Li J; Hu Q; Li Z; Feng K; Li K
Curr Mol Med; 2024; 24(3):379-388. PubMed ID: 36999424
[TBL] [Abstract][Full Text] [Related]
59. Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells.
Bataller M; Méndez C; Salas JA; Portugal J
Mol Cancer Ther; 2008 Sep; 7(9):2988-97. PubMed ID: 18790779
[TBL] [Abstract][Full Text] [Related]
60. Identification of a functional p53 responsive element within the promoter of XAF1 gene in gastrointestinal cancer cells.
Zhang W; Guo Z; Jiang B; Niu L; Xia G; Wang X; Cheng T; Zhang Y; Wang J
Int J Oncol; 2010 Apr; 36(4):1031-7. PubMed ID: 20198350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
